Atlanta Georgia Injury Attorney | Childers, Schlueter & Smith

The Dangerous Drug & Device Attorneys

Helping you pursue justice needed to move on with your life.

Our lawyers have the skill, expertise and experience needed to successfully represent those harmed in many different types of personal injury cases. We have the privilege of making sure injured victims receive the justice and compensation they deserve.

News
Defective Products
FDA Alerts

CSS Partners Listed in 2020 Best Lawyers In America Edition

Firm partners at Childers, Schlueter, & Smith, LLC, C. Andrew Childers, Richard Schlueter, and M. Brandon Smith have... Read More

FDA Issues Warnings Regarding Xeljanz (tofacitinib)

On July 26, the U.S. Food and Drug Administration (FDA) approved new warnings of an increased chance of... Read More

What does Non-Hodgkin Lymphoma Have to Do With Roundup?

Non-Hodgkin lymphoma (NHL) is a cluster of blood cancers that begins in the white blood cells and affects... Read More

Couple Awarded $2B in Third California Roundup Lawsuit

A California jury recently awarded a couple $2 billion in punitive damages and an additional $55 million for... Read More

Breaking: New Pradaxa Verdict of $542,645 – Punitive Damage Phase To Come Next

We are thrilled to report a jury in Connecticut just returned a $542,645 compensatory award to our deserving... Read More

FDA Decision Allows Generic Drug Makers to Dodge Product Liability Lawsuits

Contrary to a rule suggested by the Food and Drug Administration (FDA) in 2013 that would have allowed injured... Read More

CSS Partners Listed in 2020 Best Lawyers In America Edition

Firm partners at Childers, Schlueter, & Smith, LLC, C. Andrew Childers, Richard Schlueter, and M. Brandon Smith have... Read More

FDA Issues Warnings Regarding Xeljanz (tofacitinib)

On July 26, the U.S. Food and Drug Administration (FDA) approved new warnings of an increased chance of... Read More

What does Non-Hodgkin Lymphoma Have to Do With Roundup?

Non-Hodgkin lymphoma (NHL) is a cluster of blood cancers that begins in the white blood cells and affects... Read More

Couple Awarded $2B in Third California Roundup Lawsuit

A California jury recently awarded a couple $2 billion in punitive damages and an additional $55 million for... Read More

Breaking: New Pradaxa Verdict of $542,645 – Punitive Damage Phase To Come Next

We are thrilled to report a jury in Connecticut just returned a $542,645 compensatory award to our deserving... Read More

FDA Warns SGLT2 Inhibitors Could Lead to Fournier’s Gangrene

The U.S. Food and Drug Administration (FDA) recently warned consumers that a class of type 2 diabetes medications... Read More

FDA Issues Warnings Regarding Xeljanz (tofacitinib)

On July 26, the U.S. Food and Drug Administration (FDA) approved new warnings of an increased chance of... Read More

Breaking: New Pradaxa Verdict of $542,645 – Punitive Damage Phase To Come Next

We are thrilled to report a jury in Connecticut just returned a $542,645 compensatory award to our deserving... Read More

FDA Warns SGLT2 Inhibitors Could Lead to Fournier’s Gangrene

The U.S. Food and Drug Administration (FDA) recently warned consumers that a class of type 2 diabetes medications... Read More

FDA Decision Allows Generic Drug Makers to Dodge Product Liability Lawsuits

Contrary to a rule suggested by the Food and Drug Administration (FDA) in 2013 that would have allowed injured... Read More

Pradaxa Verdict of $1,250,000 in Favor of Plainitff

We are happy to report a jury in West Virginia just returned a $250,000 compensatory award to our... Read More

“The Bleeding Edge” Highlights FDA’s Flawed Approval Processes

While there are many innovative medical devices that have saved lives, the Food and Drug Administration’s (FDA)... Read More

Attorneys

Staff

FAQ & Resources

Personal Injury

Defective Products

Dangerous Drugs

Firm News

Video Gallery

FDA Alerts Recalls

Fearless for Your Family

The Dangerous Drug & Device Attorneys

Helping you pursue justice needed to move on with your life.

CSS Partners Listed in 2020 Best Lawyers In America Edition

FDA Issues Warnings Regarding Xeljanz (tofacitinib)

What does Non-Hodgkin Lymphoma Have to Do With Roundup?

Couple Awarded $2B in Third California Roundup Lawsuit

Breaking: New Pradaxa Verdict of $542,645 – Punitive Damage Phase To Come Next

FDA Decision Allows Generic Drug Makers to Dodge Product Liability Lawsuits

CSS Partners Listed in 2020 Best Lawyers In America Edition

FDA Issues Warnings Regarding Xeljanz (tofacitinib)

What does Non-Hodgkin Lymphoma Have to Do With Roundup?

Couple Awarded $2B in Third California Roundup Lawsuit

Breaking: New Pradaxa Verdict of $542,645 – Punitive Damage Phase To Come Next

FDA Warns SGLT2 Inhibitors Could Lead to Fournier’s Gangrene

FDA Issues Warnings Regarding Xeljanz (tofacitinib)

Breaking: New Pradaxa Verdict of $542,645 – Punitive Damage Phase To Come Next

FDA Warns SGLT2 Inhibitors Could Lead to Fournier’s Gangrene

FDA Decision Allows Generic Drug Makers to Dodge Product Liability Lawsuits

Pradaxa Verdict of $1,250,000 in Favor of Plainitff

“The Bleeding Edge” Highlights FDA’s Flawed Approval Processes